Prakash Ambady Has Been Appointed as an Associate Member at the Earle A. Chiles Research Institute
Earle A. Chiles Research Institute shared a post on LinkedIn:
“We are thrilled to announce Prakash Ambady, M.D. medical director of the Providence Neuro Oncology Program, has been appointed as an associate member at the Earle A. Chiles Research Institute, the research division of Providence Cancer Institute.
Dr. Ambady has made significant contributions to neuro-oncology through his clinical care, research and publications. Since joining Providence Brain and Spine Institute in 2022, he has been a prolific clinical investigator and is currently principal investigator on at least five clinical trials.
Dr. Ambady actively pursues collaborations with our faculty and has had a transformational impact on our neuro-oncology services at Providence.
Please join us in congratulating Dr. Ambady!”
Bernard Fox, Co-founder, President and CEO of UbiVac, shared this post, adding:
“Dr. Prakash Ambady welcome to the Earle A. Chiles Research Institute within the Providence Cancer Institute.
I look forward to working with you on a strategy that applies what we have learned about cancer’s Dark Matter/ Dark Proteome to develop a combination immunotherapy clinical trial for patients with GBM.”
More posts featuring Earle A. Chiles Research Institute.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023